Cramer Pamela J.'s Form 4 filing
Rhythm Pharmaceuticals, Inc. (RYTM) · filed Nov 12, 2025
- Accession no.
- 0001104659-25-110430
- Filed
- Nov 12, 2025
- Trade date
- Nov 7-10, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.26M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cramer Pamela J.CIK 0001873517 | Officer (Chief Human Resources Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | Common Stock | MOption exerciseAcquired | +8,805 | $19.02 | +$167,471.1 | 29,619 | Direct | |
| Nov 7, 2025 | Common Stock | MOption exerciseAcquired | +10,546 | $6.80 | +$71,712.8 | 40,165 | Direct | |
| Nov 7, 2025 | Common Stock | SSaleDisposed | −19,351 | $98.82 | −$1,912,265.82 | 20,814 | Direct | |
| Nov 10, 2025 | Common Stock | MOption exerciseAcquired | +3,515 | $6.80 | +$23,902 | 24,329 | Direct | |
| Nov 10, 2025 | Common Stock | SSaleDisposed | −3,515 | $100.00 | −$351,500 | 20,814 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | Common Stock | MOption exerciseDisposed | −8,805 | $0.00 | $0 | 5,257 | Direct | |
| Nov 7, 2025 | Common Stock | MOption exerciseDisposed | −10,546 | $0.00 | $0 | 7,035 | Direct | |
| Nov 10, 2025 | Common Stock | MOption exerciseDisposed | −3,515 | $0.00 | $0 | 3,520 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.